StonvexLoading…
StonvexStonvexStonvexCore line items from OKE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $33.63B | $21.70B | $17.68B | $22.39B |
Operating Income | $5.74B | $4.99B | $4.07B | $2.81B |
Net Income | $3.39B | $3.04B | $2.66B | $1.72B |
EPS (Diluted) | $5.42 | $5.17 | $5.48 | $3.84 |
Total Assets | $66.64B | $64.07B | $44.27B | $24.38B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $78.00M | $733.00M | $338.00M | $220.00M |
Free Cash Flow OCF − CapEx | $2.45B | $2.87B | $2.83B | $1.70B |
Shares Outstanding | 629.71M | 583.11M | 583.09M | 447.16M |